XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Class A and Class B common stock
Additional Paid-in Capital
Accumulated other comprehensive loss
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 294,969 $ 1 $ 568,889 $ (754) $ (273,167)
Beginning balance, shares at Dec. 31, 2022   114,199,000      
Stock-based compensation expense 20,409   20,409    
Exercise of stock options 1,687   1,687    
Exercise of stock options, shares   554,000      
Vesting of early exercised stock options 198   198    
Vesting of restricted stock units, shares   875,000      
Repurchase of unvested stock options, shares   (46,000)      
Net Income (Loss) (26,315)       (26,315)
Other comprehensive income (loss), net 272     272  
Ending balance at Mar. 31, 2023 291,220 $ 1 591,183 (482) (299,482)
Ending balance, shares at Mar. 31, 2023   115,582,000      
Beginning balance at Dec. 31, 2022 294,969 $ 1 568,889 (754) (273,167)
Beginning balance, shares at Dec. 31, 2022   114,199,000      
Net Income (Loss) (71,820)        
Ending balance at Sep. 30, 2023 291,574 $ 1 637,157 (597) (344,987)
Ending balance, shares at Sep. 30, 2023   118,796,000      
Beginning balance at Mar. 31, 2023 291,220 $ 1 591,183 (482) (299,482)
Beginning balance, shares at Mar. 31, 2023   115,582,000      
Stock-based compensation expense 22,300   22,300    
Exercise of stock options 699   699    
Exercise of stock options, shares   228,000      
Issuance of common stock under employee share purchase plan 2,564   2,564    
Issuance of common stock under employee share purchase plan, Shares   302,000      
Vesting of early exercised stock options 207   207    
Vesting of restricted stock units, shares   1,378,000      
Net Income (Loss) (27,758)       (27,758)
Other comprehensive income (loss), net (382)     (382)  
Ending balance at Jun. 30, 2023 288,850 $ 1 616,953 (864) (327,240)
Ending balance, shares at Jun. 30, 2023   117,490,000      
Stock-based compensation expense 23,593   23,593    
Exercise of stock options 1,183   1,183    
Exercise of stock options, shares   528,000      
Vesting of early exercised stock options 155   155    
Vesting of restricted stock units, shares   1,193,000      
Tax withholding on net share settlement of restricted stock units (4,727)   (4,727)    
Tax withholding on net share settlement of restricted stock units, shares   (415,000)      
Net Income (Loss) (17,747)       (17,747)
Other comprehensive income (loss), net 267     267  
Ending balance at Sep. 30, 2023 291,574 $ 1 637,157 (597) (344,987)
Ending balance, shares at Sep. 30, 2023   118,796,000      
Beginning balance at Dec. 31, 2023 294,753 $ 1 658,463 (181) (363,530)
Beginning balance, shares at Dec. 31, 2023   120,010,000      
Stock-based compensation expense 21,765   21,765    
Exercise of stock options 1,794   1,794    
Exercise of stock options, shares   699,000      
Vesting of early exercised stock options 20   20    
Vesting of restricted stock units, shares   1,442,000      
Tax withholding on net share settlement of restricted stock units (7,729)   (7,729)    
Tax withholding on net share settlement of restricted stock units, shares   (542,000)      
Net Income (Loss) (21,460)       (21,460)
Other comprehensive income (loss), net 67     67  
Ending balance at Mar. 31, 2024 289,210 $ 1 674,313 (114) (384,990)
Ending balance, shares at Mar. 31, 2024   121,609,000      
Beginning balance at Dec. 31, 2023 $ 294,753 $ 1 658,463 (181) (363,530)
Beginning balance, shares at Dec. 31, 2023   120,010,000      
Exercise of stock options, shares 2,031,678        
Net Income (Loss) $ (61,729)        
Ending balance at Sep. 30, 2024 290,027 $ 1 715,285 0 (425,259)
Ending balance, shares at Sep. 30, 2024   125,432,000      
Beginning balance at Mar. 31, 2024 289,210 $ 1 674,313 (114) (384,990)
Beginning balance, shares at Mar. 31, 2024   121,609,000      
Stock-based compensation expense 24,421   24,421    
Exercise of stock options 1,463   1,463    
Exercise of stock options, shares   503,000      
Issuance of common stock under employee share purchase plan 2,030   2,030    
Issuance of common stock under employee share purchase plan, Shares   256,000      
Vesting of restricted stock units, shares   1,847,000      
Tax withholding on net share settlement of restricted stock units (6,449)   (6,449)    
Tax withholding on net share settlement of restricted stock units, shares   (680,000)      
Net Income (Loss) (23,415)       (23,415)
Other comprehensive income (loss), net 67     67  
Ending balance at Jun. 30, 2024 287,327 $ 1 695,778 (47) (408,405)
Ending balance, shares at Jun. 30, 2024   123,535,000      
Stock-based compensation expense 22,792   22,792    
Exercise of stock options 2,346   2,346    
Exercise of stock options, shares   830,000      
Vesting of restricted stock units, shares   1,730,000      
Tax withholding on net share settlement of restricted stock units (5,631)   (5,631)    
Tax withholding on net share settlement of restricted stock units, shares   (663,000)      
Net Income (Loss) (16,854)       (16,854)
Other comprehensive income (loss), net 47     47
Ending balance at Sep. 30, 2024 $ 290,027 $ 1 $ 715,285 $ 0 $ (425,259)
Ending balance, shares at Sep. 30, 2024   125,432,000